Latest Conference Articles

EURETINA 2021 Virtual Congress in review

EURETINA 2021 Virtual Congress in review

September 14th 2021, 7:08am

EURETINA

A post-conference guide for ophthalmologists after the conclusion of EURETINA 2021.

Providing optimal care for patients with diabetic eye disease

Providing optimal care for patients with diabetic eye disease

September 12th 2021, 10:04am

EURETINA

Prof Tunde Peto discusses her presentation on providing the best virtual care for patients with diabetic eye disease at EURETINA 2021.

LIGHTSITE II study: Photobiomodulation treatment improves vision in eyes with dry AMD

LIGHTSITE II study: Photobiomodulation treatment improves vision in eyes with dry AMD

September 12th 2021, 9:03am

EURETINA

During a presentation at the EURETINA 2021 Virtual Congress, Prof. Ben Burton detailed how dry AMD patients treated with photobiomodulation therapy have seen improvements in best-corrected visual acuity 9 months after treatment.

Key to beating diabetes is better understanding for ophthalmologists

Key to beating diabetes is better understanding for ophthalmologists

September 12th 2021, 8:30am

EURETINA

Health systems are challenged to provide appropriate care for the ever-increasing number of patients with diabetes and its complications, such as diabetic retinopathy and diabetic macular oedema.

Exploring the clinical and humanistic burden of geographic atrophy

Exploring the clinical and humanistic burden of geographic atrophy

September 11th 2021, 12:59pm

EURETINA

During a presentation at the EURETINA 2021 Virtual Congress, Dr Daniel Jones discussed GA and emphasized the need for additional study to gain a better understanding of the burden experienced by patients.

Brolucizumab injection improves vision in eyes with neovascular AMD

Brolucizumab injection improves vision in eyes with neovascular AMD

September 11th 2021, 12:15pm

EURETINA

In a presentation at the EURETINA 2021 Virtual Congress, Dr Cristina Cristian noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated.

Worldwide pathological myopia discussed by panel at EURETINA 2021

Worldwide pathological myopia discussed by panel at EURETINA 2021

September 11th 2021, 11:15am

EURETINA

Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.

Role of anterior vitreous, managing retinal folds in retinal detachment cases

Role of anterior vitreous, managing retinal folds in retinal detachment cases

September 11th 2021, 9:07am

EURETINA

Dr Grazia Pertile discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.

Analysis of macula dystrophy classifications

Analysis of macula dystrophy classifications

September 11th 2021, 12:28am

EURETINA

Prof Carel B. Hoyng discusses his presenation regarding macula dystrophies, including Stargardt disease, Best disease, X-linked retinoschisis, and the peripherin-2 (PRPH2) gene.

AI for nAMD: Capturing more information from OCT

AI for nAMD: Capturing more information from OCT

September 10th 2021, 2:00pm

EURETINA

During a presentation at the EURETINA 2021 Virtual Congress, Dr Anat Loewenstein discussed how artificial intelligence can optimize optical coherence tomography.